Brief: Oncbiomune signs term sheet to acquire Vitel Laboratorios, S.A. De C.V.
03/11/2016 12:00
Nov 3 (Reuters) - Oncbiomune Pharmaceuticals Inc OBMP.PK :
* Oncbiomune signs term sheet to acquire Vitel Laboratorios,
s.a. De c.v.
Source text for Eikon: ID:nMKWdR0dLa
Further company coverage: OBMP.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Theralink Technologies
See all newsBrief: IMAC Holdings - Theralink Will Merge With Newly-Formed Unit Of IMAC In A Stock-For-Stock Reverse Merger Transaction
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say (updated)
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
Brief: Theralink Technologies Appoints Faith Zaslavsky As President, COO
Brief: Theralink Technologies Appoints Mattia Cremona As Director Of Its Biopharma Laboratory